Concepedia

Publication | Closed Access

A phase 2a proof of concept clinical trial to evaluate ZPL-3893787 (ZPL-389) a potent, oral histamine H4, receptor antagonist for the treatment of moderate to severe atopic dermatitis (AD) in adults

15

Citations

0

References

2016

Year

Thomas Werfel, Victoria Lynch, Aliya Asher, Athanasios Tsianakas, Bhanu Gupta, R. Sarmiento, Anna Płoszczuk, Bernadetta Majorek‐Olechowska, B. Cimoszko, Arjen Nikkels,
Open Repository and Bibliography (University of Liège)

Abstract

peer reviewed